LIFEARC
Patent Applications and Registrations
Patent applications and USPTO patent grants for LIFEARC.The latest application filed is for "humanised anti-il17br antibody".
- LIFEARC - London GB
- LIFEARC - Greater London GB
- LIFEARC - London, Greater London GB
Trademarks
| Patent | Date |
|---|---|
| Composition for treating one or more estrogen related diseases Grant 11,446,351 - Larsen , et al. September 20, 2 | 2022-09-20 |
| Humanised Anti-il17br Antibody App 20220041740 - Patel; Seema ; et al. | 2022-02-10 |
| Humanised Anti-n-truncated Amyloid Beta Monoclonal Antibody App 20210347867 - BAYER; Thomas ; et al. | 2021-11-11 |
| Fused thiazolopyrimidine derivatives as MNKs inhibitors Grant 11,136,338 - Winter-Holt , et al. October 5, 2 | 2021-10-05 |
| Anti-Transglutaminase 2 Antibodies App 20210101999 - Johnson; Tim ; et al. | 2021-04-08 |
| Oxazole derivatives for use in the treatment of cancer Grant 10,961,233 - Osborne , et al. March 30, 2 | 2021-03-30 |
| Anti-transglutaminase 2 antibodies Grant 10,961,319 - Johnson , et al. March 30, 2 | 2021-03-30 |
| Oxazole derivatives for use in the treatment of cancer Grant 10,961,234 - Osborne , et al. March 30, 2 | 2021-03-30 |
| A Composition For Treating One Or More Estrogen Related Diseases App 20210052692 - LARSEN; Finn ; et al. | 2021-02-25 |
| Substituted tricyclic heterocyclic compounds and use thereof Grant 10,918,645 - Xia , et al. February 16, 2 | 2021-02-16 |
| Humanized Antibodies Against Enterovirus 71 App 20200317753 - CREIGH-PULATMEN; Tilbe ; et al. | 2020-10-08 |
| Fused Thiazolopyrimidine Derivatives As MNKS Inhibitors App 20200247822 - Kind Code | 2020-08-06 |
| Fused thiazolopyrimidine derivatives as MNKS inhibitors Grant 10,669,284 - Winter-Holt , et al. | 2020-06-02 |
| Pyrropyrimidine compounds as MNKs inhibitors Grant 10,604,524 - Winter-Holt , et al. | 2020-03-31 |
| Oxazole Derivatives For Use In The Treatment Of Cancer App 20190352296 - OSBORNE; Simon ; et al. | 2019-11-21 |
| Oxazole Derivatives For Use In The Treatment Of Cancer App 20190352295 - OSBORNE; Simon ; et al. | 2019-11-21 |
| Substituted Tricyclic Heterocyclic Compounds And Use Thereof App 20190307763 - XIA; Yan ; et al. | 2019-10-10 |
| Anti-Transglutaminase 2 Antibodies App 20180355060 - Johnson; Tim ; et al. | 2018-12-13 |
| Pyrropyrimidine Compounds As MNKS Inhibitors App 20180346469 - Winter-Holt; Jon James ; et al. | 2018-12-06 |
| Fused Thiazolopyrimidine Derivatives As MNKS Inhibitors App 20180346483 - Winter-Holt; Jon James ; et al. | 2018-12-06 |
| Anti-transglutaminase 2 antibodies Grant 10,005,846 - Johnson , et al. June 26, 2 | 2018-06-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 